Novo Nordisk Roars Back: 6 Catalysts Driving the Pharma's Path to Dominance
Novo Nordisk regained momentum in the GLP-1 market after competition and shortages, driven by strategic wins, resolved shortages, and expanded drug indications, boosting its stock.
GPs ration common painkiller used to treat inflammation and back problems
Widespread shortages of Diclac tablets are occurring as demand unexpectedly rises, limiting availability of this common non-steroidal anti-inflammatory painkiller.
Republicans Want You to Pay More at the Pharmacy -- Or Die
Trump's proposed pharmaceutical tariffs threaten to drastically increase medication costs, affecting millions of Americans who rely on prescription drugs.
Republicans Want You to Pay More at the Pharmacy -- Or Die
Trump's proposed pharmaceutical tariffs threaten to drastically increase medication costs, affecting millions of Americans who rely on prescription drugs.